Martin Carroll Selected Research

Martin Carroll Research Topics

Disease

38	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 08/2003
27	Leukemia 05/2024 - 11/2003
21	Neoplasms (Cancer) 05/2024 - 06/2007
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 02/2006
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 05/2006
2	Multiple Myeloma 05/2024 - 01/2024
2	Immunoglobulin Light-chain Amyloidosis 05/2024 - 01/2024
2	Monoclonal Gammopathy of Undetermined Significance 05/2024 - 01/2024
2	Philadelphia Chromosome 01/2020 - 12/2017
2	Hematologic Neoplasms (Hematological Malignancy) 04/2015 - 04/2010
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2011 - 01/2007
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2006 - 03/2002
1	Leukemic Infiltration 01/2024
1	Acute Biphenotypic Leukemia (Leukemia, Mixed Cell) 10/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2021
1	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2020
1	Leukostasis 01/2018
1	Infections 01/2018
1	Genomic Instability 01/2017
1	Neoplasm Metastasis (Metastasis) 04/2015

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2002
5	Phosphotransferases (Kinase)IBA 01/2019 - 08/2007
4	CytokinesIBA 10/2021 - 10/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 06/2007
3	fms-Like Tyrosine Kinase 3IBA 01/2024 - 01/2019
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2024 - 06/2008
3	EnzymesIBA 01/2022 - 03/2010
3	Sirolimus (Rapamycin)FDA Link 01/2018 - 11/2009
3	bcr-abl Fusion ProteinsIBA 10/2011 - 03/2004
2	Busulfan (Busulfex)FDA Link 05/2024 - 01/2024
2	Bortezomib (Velcade)FDA Link 05/2024 - 01/2024
2	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2020
2	ChromatinIBA 11/2022 - 09/2011
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 01/2007
2	gilteritinibIBA 01/2019 - 01/2019
2	CytosineIBA 01/2019 - 01/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2018 - 12/2017
2	TOR Serine-Threonine KinasesIBA 01/2018 - 11/2009
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2017 - 03/2012
2	Chimeric Antigen ReceptorsIBA 01/2017 - 04/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015 - 10/2010
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2013 - 03/2010
2	alpha-hydroxyglutarateIBA 06/2013 - 03/2010
2	MTOR InhibitorsIBA 09/2008 - 10/2007
2	Bexarotene (LGD1069)FDA Link 09/2008 - 01/2007
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 12/2005 - 08/2003
1	Small Cytoplasmic RNAIBA 01/2024
1	Interferon Type IIBA 01/2023
1	LipidsIBA 01/2023
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2023
1	Interleukin-15 (Interleukin 15)IBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	Lysine (L-Lysine)FDA Link 11/2022
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2022
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022
1	KynurenineIBA 01/2022
1	Serotonin (5 Hydroxytryptamine)IBA 01/2022
1	Serotonin ReceptorsIBA 01/2022
1	CalciumIBA 10/2021
1	Apoptosis Regulatory ProteinsIBA 01/2020
1	Histones (Histone)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	RNA Splicing FactorsIBA 11/2018
1	Inflammation MediatorsIBA 01/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2017
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2017
1	N-methyladenosineIBA 11/2017
1	6-methyladenineIBA 11/2017
1	Messenger RNA (mRNA)IBA 11/2017
1	NucleotidesIBA 11/2017
1	MethyltransferasesIBA 01/2017
1	AnthracyclinesIBA 04/2015
1	DNA Methyltransferase 3AIBA 04/2015
1	Thrombopoietin (c-mpl Ligand)IBA 01/2015
1	eltrombopag FDA Link 01/2015
1	CaspasesIBA 01/2015
1	Tyrosine (L-Tyrosine)FDA Link 04/2014
1	crenolanibIBA 04/2014
1	quizartinibIBA 04/2014
1	Tyrosine Kinase InhibitorsIBA 04/2014
1	perifosineIBA 10/2013
1	7-hydroxystaurosporine (UCN 01)IBA 10/2013
1	Eukaryotic Initiation Factor-4EIBA 05/2013
1	Peptide Initiation Factors (Initiation Factor)IBA 05/2013
1	Etoposide (VP 16)FDA LinkGeneric 03/2012
1	Mitoxantrone (Novantrone)FDA LinkGeneric 03/2012
1	Imatinib Mesylate (Gleevec)FDA Link 10/2011

Therapy/Procedure

12	Therapeutics 10/2021 - 02/2006
11	Drug Therapy (Chemotherapy) 11/2021 - 05/2006
2	Heterologous Transplantation (Xenotransplantation) 01/2018 - 01/2011
2	Hematopoietic Stem Cell Transplantation 01/2017 - 11/2016
1	Remission Induction 01/2018
1	Stem Cell Transplantation 11/2016
1	Transplantation 11/2016
1	Microspheres (Microsphere) 03/2014